Drug Patent Expirations in September 2013

Drug Patent Expirations for September 2013

Tradename Applicant Generic Name Patent Number Patent Expiration
LUPRON DEPOT Abbvie Endocrine Inc leuprolide acetate 5,575,987 Sep 2, 2013
LUPRON DEPOT-PED Abbott Endocrine leuprolide acetate 5,575,987 Sep 2, 2013
LUPRON DEPOT Abbott Endocrine leuprolide acetate 5,716,640 Sep 2, 2013
LUPRON DEPOT Abbvie Endocrine Inc leuprolide acetate 5,716,640 Sep 2, 2013
LUPRON DEPOT-PED Abbott Endocrine leuprolide acetate 5,716,640 Sep 2, 2013
LUPRON DEPOT Abbott Endocrine leuprolide acetate 5,575,987 Sep 2, 2013
SYMLIN Amylin Pharms Llc pramlintide acetate 6,608,029 Sep 7, 2013
OPANA ER Endo Pharms oxymorphone hydrochloride 5,662,933 Sep 9, 2013
OPANA ER Endo Pharms oxymorphone hydrochloride 5,958,456 Sep 9, 2013
MYRBETRIQ Apgdi mirabegron 6,699,503 Sep 10, 2013
PRELAY Sankyo troglitazone 6,046,202 Sep 15, 2013
CELLCEPT Roche Palo mycophenolate mofetil hydrochloride 5,543,408 Sep 15, 2013
REZULIN Pfizer Pharms troglitazone 5,602,133 Sep 15, 2013
CRINONE Watson Labs progesterone 5,543,150 Sep 15, 2013
PRELAY Sankyo troglitazone 5,602,133 Sep 15, 2013
REZULIN Pfizer Pharms troglitazone 6,046,202 Sep 15, 2013
CANCIDAS Merck caspofungin acetate 5,792,746*PED Sep 16, 2013
CANCIDAS Merck caspofungin acetate 5,378,804*PED Sep 16, 2013
AVODART Glaxosmithkline dutasteride 5,846,976 Sep 17, 2013
JALYN Glaxosmithkline dutasteride; tamsulosin hydrochloride 5,846,976 Sep 17, 2013
DIASTAT ACUDIAL Valeant diazepam 5,462,740 Sep 17, 2013
AVODART Glaxosmithkline dutasteride 5,998,427 Sep 17, 2013
JALYN Glaxosmithkline dutasteride; tamsulosin hydrochloride 5,998,427 Sep 17, 2013
DIASTAT Valeant diazepam 5,462,740 Sep 17, 2013
NIASPAN Abbvie niacin 6,406,715 Sep 20, 2013
ADVICOR Abbvie lovastatin; niacin 6,746,691 Sep 20, 2013
SIMCOR Abbvie niacin; simvastatin 6,676,967 Sep 20, 2013
NIASPAN Abbvie niacin 7,998,506 Sep 20, 2013
ADVICOR Abbvie lovastatin; niacin 6,818,229 Sep 20, 2013
SIMCOR Abbvie niacin; simvastatin 6,818,229 Sep 20, 2013
NIASPAN Abbvie niacin 6,746,691 Sep 20, 2013
SIMCOR Abbvie niacin; simvastatin 7,998,506 Sep 20, 2013
ADVICOR Abbvie lovastatin; niacin 6,406,715 Sep 20, 2013
NIASPAN TITRATION STARTER PACK Abbvie niacin 6,129,930 Sep 20, 2013
NIASPAN Abbvie niacin 6,676,967 Sep 20, 2013
SIMCOR Abbvie niacin; simvastatin 6,406,715 Sep 20, 2013
ADVICOR Abbvie lovastatin; niacin 7,998,506 Sep 20, 2013
NIASPAN TITRATION STARTER PACK Abbvie niacin 6,746,691 Sep 20, 2013
NIASPAN Abbvie niacin 7,011,848 Sep 20, 2013
ADVICOR Abbvie lovastatin; niacin 6,676,967 Sep 20, 2013
SIMCOR Abbvie niacin; simvastatin 6,746,691 Sep 20, 2013
NIASPAN Abbvie niacin 6,818,229 Sep 20, 2013
SIMCOR Abbvie niacin; simvastatin 7,011,848 Sep 20, 2013
ADVICOR Abbvie lovastatin; niacin 6,129,930 Sep 20, 2013
NIASPAN TITRATION STARTER PACK Abbvie niacin 7,011,848 Sep 20, 2013
NIASPAN Abbvie niacin 6,129,930 Sep 20, 2013
SIMCOR Abbvie niacin; simvastatin 6,129,930 Sep 20, 2013
ADVICOR Abbvie lovastatin; niacin 7,011,848 Sep 20, 2013
NIASPAN TITRATION STARTER PACK Abbvie niacin 6,406,715 Sep 20, 2013
ZYFLO CR Cornerstone Therap zileuton 6,183,778 Sep 21, 2013
NOVOLOG MIX 70/30 FLEXPEN Novo Nordisk Inc insulin aspart protamine recombinant; insulin aspart recombinant 5,834,422 Sep 28, 2013
NOVOLOG MIX 50/50 Novo Nordisk Inc insulin aspart protamine recombinant; insulin aspart recombinant 5,840,680 Sep 28, 2013
NOVOLOG MIX 70/30 PENFILL Novo Nordisk Inc insulin aspart protamine recombinant; insulin aspart recombinant 5,834,422 Sep 28, 2013
NOVOLOG MIX 50/50 Novo Nordisk Inc insulin aspart protamine recombinant; insulin aspart recombinant 5,834,422 Sep 28, 2013
ELIGARD Tolmar Therap leuprolide acetate 6,395,293 Sep 28, 2013
NOVOLOG MIX 70/30 PENFILL Novo Nordisk Inc insulin aspart protamine recombinant; insulin aspart recombinant 5,547,930 Sep 28, 2013
NOVOLOG MIX 70/30 Novo Nordisk Inc insulin aspart protamine recombinant; insulin aspart recombinant 5,840,680 Sep 28, 2013
NOVOLOG MIX 70/30 FLEXPEN Novo Nordisk Inc insulin aspart protamine recombinant; insulin aspart recombinant 5,547,930 Sep 28, 2013
NOVOLOG MIX 70/30 FLEXPEN Novo Nordisk Inc insulin aspart protamine recombinant; insulin aspart recombinant 5,840,680 Sep 28, 2013
NOVOLOG MIX 50/50 Novo Nordisk Inc insulin aspart protamine recombinant; insulin aspart recombinant 5,547,930 Sep 28, 2013
NOVOLOG MIX 70/30 PENFILL Novo Nordisk Inc insulin aspart protamine recombinant; insulin aspart recombinant 5,840,680 Sep 28, 2013
NOVOLOG MIX 70/30 Novo Nordisk Inc insulin aspart protamine recombinant; insulin aspart recombinant 5,547,930 Sep 28, 2013
NOVOLOG MIX 70/30 Novo Nordisk Inc insulin aspart protamine recombinant; insulin aspart recombinant 5,834,422 Sep 28, 2013
COMBIVENT RESPIMAT Boehringer Ingelheim albuterol sulfate; ipratropium bromide 5,911,851 Sep 29, 2013
COMBIVENT RESPIMAT Boehringer Ingelheim albuterol sulfate; ipratropium bromide 6,503,362 Sep 29, 2013
COMBIVENT RESPIMAT Boehringer Ingelheim albuterol sulfate; ipratropium bromide 6,007,676 Sep 29, 2013
COMBIVENT RESPIMAT Boehringer Ingelheim albuterol sulfate; ipratropium bromide 5,472,143 Sep 29, 2013
LIDOSITE TOPICAL SYSTEM KIT Vyteris epinephrine; lidocaine hydrochloride 5,873,850 Sep 30, 2013
LEVULAN Dusa aminolevulinic acid hydrochloride 5,079,262 Sep 30, 2013
LIDOSITE TOPICAL SYSTEM KIT Vyteris epinephrine; lidocaine hydrochloride 6,385,488 Sep 30, 2013
LIDOSITE TOPICAL SYSTEM KIT Vyteris epinephrine; lidocaine hydrochloride 6,377,847 Sep 30, 2013
LIDOSITE TOPICAL SYSTEM KIT Vyteris epinephrine; lidocaine hydrochloride 5,246,418 Sep 30, 2013
LIDOSITE TOPICAL SYSTEM KIT Vyteris epinephrine; lidocaine hydrochloride 6,862,473 Sep 30, 2013
*Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatch database for complete details.

Subscribers have access to valuable datasets, including:

  • Clinical trial information
  • International patent families
  • International patent priority and PCT information
  • Patent maintenance
  • Full-text patent downloads
  • Sales data (top 200 drugs)
  • Paragraph IV challenges
  • Tentative approvals
  • Dynamic search capabilities with data export
  • More…
See the Database Preview and Plan Comparison.
Contact Us with any questions.

Comments are closed.